Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ESWT vs Orthosis in Trigger Finger

NCT: NCT06737601 · ENROLLING_BY_INVITATION

NCT IDNCT06737601
StatusENROLLING_BY_INVITATION
Start Date2025-11-15
Completion2028-01-01

Brief Summary

Recently, two works have proposed the application of Extracorporeal Shock Waves Therapy (ESWT) in the treatment of trigger finger. Yildirim and colleagues (2016) compared shock waves with corticosteroid infiltration. both methods proved effective at 6 months. The authors suggested that shock wave treatment could be a valid non-invasive therapy option for this pathology. Chen and colleagues (2021) analyzed two different shock wave protocols \[high and low Energy Density Flux (EDF)\] vs placebo. All treatment groups showed improvements within 6 months. The high-energy treatment (EDF 0.01 mj/mm2) demonstrated greater effects on clinical remission and functional recovery compared to the other two groups in the study. The aim of our study is to compare the effects of shock waves vs the use of the orthosis.

Frequently Asked Questions

What is ESWT vs Orthosis in Trigger Finger?

ESWT vs Orthosis in Trigger Finger is a clinical trial registered under NCT06737601. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06737601?

The current status of NCT06737601 (ESWT vs Orthosis in Trigger Finger) is: ENROLLING_BY_INVITATION.

When did ESWT vs Orthosis in Trigger Finger start?

ESWT vs Orthosis in Trigger Finger started on 2025-11-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.